+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers



Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers



Annals of Nuclear Medicine 29(1): 91-99



The severity of chronic obstructive lung disease (COPD) is defined by the degree of flow limitation measured as forced expiratory volume in 1 s, which mainly reflects impairment of large and intermediate airways. However, COPD is primarily a small airways disease. Therefore, better diagnostic tools are needed. Ventilation-Perfusion (V/P) SPECT is a sensitive method to detect obstructive lung changes but criteria for staging airway obstruction are missing. To define and validate criteria to stage COPD using V/P SPECT. 74 subjects (healthy non-smokers, healthy smokers or with stable COPD) were included. All were examined with V/P SPECT in a hybrid SPECT/CT system. Spirometry was performed and patients were evaluated with the clinical COPD questionnaire (CCQ). V/P SPECT was interpreted independently. Preserved lung function (%) was evaluated. The degree of airway obstruction on V/P SPECT was graded according to newly-developed grading criteria. The degree of airway obstruction was graded from normal (0) to severe (3). The airway obstructivity-grade and degree of preserved lung function were compared to GOLD, CCQ and LDCT emphysema extent. Obstructivity-grade (r = 0.66, P < 0.001) and the degree of preserved lung function (r = -0.70, P < 0.001) both correlated to GOLD. Total preserved lung function decreased in relation to higher GOLD stage. There was a significant difference between healthy controls and apparently healthy long time smokers both regarding obstructivity-grade (P = 0.001) and preserved lung function (P < 0.001). Long-time smokers did not differ significantly from GOLD 1 COPD patients (P = 0.14 and P = 0.55 for obstructivity-grade and preserved lung function, respectively). However, patients in GOLD 1 differed in obstructivity-grade from non-smoking controls (P = 0.02). Functional imaging with V/P SPECT enables standardized grading of airway obstruction as well as reduced lung function, both of which correlate with GOLD stage. V/P SPECT shows that long-term smokers in most cases have signs of ventilatory impairment and airway obstruction not shown by spirometry.

(PDF emailed within 0-6 h: $19.90)

Accession: 053437391

Download citation: RISBibTeXText

PMID: 25315109

DOI: 10.1007/s12149-014-0913-y


Related references

Patients with chronic obstructive pulmonary disease (COPD)--similarities and differences of the study group participating in the project of National Center for Research and Development project "Chronic obstructive pulmonary disease (COPD)--systemic disease, the biggest threat of XXI century". Polski Merkuriusz Lekarski 39(234): 359-363, 2016

Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers. International Immunopharmacology 15(1): 58-66, 2013

Evaluation of the regional lung function revealed in radioaerosol scintigram of chronic obstructive pulmonary disease. II. Evaluation of aerodynamic change in the airway of patients with chronic obstructive pulmonary disease using radioaerosol scintigraphy. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 40(4): 355-364, 1980

Correlation of chronic obstructive pulmonary disease assessment test and clinical chronic obstructive pulmonary disease questionnaire score with BODE index in patients of stable chronic obstructive pulmonary disease. Lung India 35(6): 494-498, 2018

Efficacy Outcomes With Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) According to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification at Baseline in Patients With Chronic Obstructive Pulmonary Disease (COPD). Chest Journal 144(4): 729a-729b, 2013

Long term effects on protriptyline ptp in patients with chronic obstructive pulmonary disease copd. American Review of Respiratory Disease 145(4 PART 2): A172, 1992

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. New England Journal of Medicine 340(25): 1948-1953, 1999

Long-term Prognosis of Chronic Obstructive Pulmonary Disease (COPD) Patients on Home Oxygenotherapy. Chest Journal 145(3): 383a-1-383a-2, 2014

Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. Journal of the American Medical Directors Association 18(12): 1063-1068, 2018

Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respiratory Medicine 101(9): 1954-1960, 2007

U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations. Respiration; International Review of Thoracic Diseases 82(4): 320-327, 2012

The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD). Internal Medicine 56(20): 2711-2717, 2017

Chronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease : Advances on the diagnosis and treatment.Diagnosis and disease state.Disturbance of pulmonary circulation of COPD. Nihon Naika Gakkai Zasshi 84(5): 721-725, 1995

Chronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease : Advances on the diagnosis and treatment.Diagnosis and disease state.Clinical manifestation and physical findings of COPD. Nihon Naika Gakkai Zasshi 84(5): 699-703, 1995

Chronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease : Advances on the diagnosis and treatment.Diagnosis and disease state.Histopathology of a disease group presenting COPD. Nihon Naika Gakkai Zasshi 84(5): 730-734, 1995